You are here: Home :: Keyword index :: ret bis sol :: Risikofaktoren - RNA world risk factor

Items for "risk factor"

An Intelligent Data Mining Model Approach for Adverse Effects of Hormone Replacement Therapy

OBJECTIVES: A number of controversial studies have been reported on the potential risk of breast cancer caused by hormone replacement therapy (HRT)...

Keywords: Estrogen, breast cancer, hormone therapy, side effects, risk factor, cohort study, observation study and casecontrol study

01/2007 | Methods of Information in Medicine, Schattauer

Factor XIII Val34Leu variant and the risk of myocardial infarction. A meta-analysis

Genetic factors are thought to contribute to the pathogenesis of acute myocardial infarction (AMI). A common variant of factor XIII (FXIII), FXIII Val34Leu, may be protective against developing an AMI, but various studies show conflicting results...

Keywords: factor XIII, genetic, meta-analysis, myocardial infarction, risk factor

04/2007 | Thrombosis and Haemostasis, Schattauer

Within-subject variation of plasma resistin levels over a 1-year period

Background: Resistin, a recently discovered hormone, is purportedly involved in metabolic and inflammatory processes in humans and may thus be an important marker to assess disease risk in large-scale epidemiological studies.

Methods: We assessed the reliability of human resistin levels in 63 men and 51 women aged 35–67 years with repeated measurements of resistin over a period of 1 year...

Keywords: biomarker, inflammation, obesity, reliability, risk factor

07/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter

Risk factors and outcomes for ventilator-associated pneumonia in neonatal intensive care unit patients

In order to determine the risk factors and outcomes of ventilator-associated pneumonia (VAP) in the neonatal intensive care unit (NICU), a retrospective cohort study was conducted on 259 patients who were ventilated >48 h...

Keywords: Neonatal intensive care unit, risk factor, ventilator-associated pneumonia

03/2007 | Journal of Perinatal Medicine, Walter de Gruyter

Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay

Asymmetric dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide synthase (NOS)...

Keywords: dimethylarginine, endothelial dysfunction, inhibitor, NO pathway, risk factor

12/2004 | Clinical Chemical Laboratory Medicine, Walter de Gruyter

The ?374A allele of the receptor for advanced glycation end products (RAGE) gene promoter is a protective factor against cardiovascular lesions in type 2 diabetes mellitus patients

Background: Polymorphisms of the receptor for advanced glycation end products (RAGE) gene have been associated with diabetes, coronary artery disease (CAD) and inflammatory processes...

Keywords: advanced glycation end products, coronary artery disease, disease severity, Euro-Brazilians, risk factor, single nucleotide polymorphism, type 2 diabetes

10/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter

Publisher and Institutes